These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 2831259)
21. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. Silver PJ; Lepore RE; O'Connor B; Lemp BM; Hamel LT; Bentley RG; Harris AL J Pharmacol Exp Ther; 1988 Oct; 247(1):34-42. PubMed ID: 2845058 [TBL] [Abstract][Full Text] [Related]
22. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities. Lugnier C; Gauthier C; Le Bec A; Soustre H Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036 [TBL] [Abstract][Full Text] [Related]
23. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium. Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013 [TBL] [Abstract][Full Text] [Related]
24. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages. Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385 [TBL] [Abstract][Full Text] [Related]
25. Regulation of calcium current by low-Km cyclic AMP phosphodiesterases in cardiac cells. Fischmeister R; Hartzell HC Mol Pharmacol; 1990 Sep; 38(3):426-33. PubMed ID: 1698253 [TBL] [Abstract][Full Text] [Related]
26. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089 [TBL] [Abstract][Full Text] [Related]
27. Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. Harris AL; Connell MJ; Ferguson EW; Wallace AM; Gordon RJ; Pagani ED; Silver PJ J Pharmacol Exp Ther; 1989 Oct; 251(1):199-206. PubMed ID: 2552074 [TBL] [Abstract][Full Text] [Related]
28. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria. Muller B; Lugnier C; Stoclet JC J Cardiovasc Pharmacol; 1990 Mar; 15(3):444-51. PubMed ID: 1691369 [TBL] [Abstract][Full Text] [Related]
29. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810 [TBL] [Abstract][Full Text] [Related]
30. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism. Ahn HS; Eardley D; Watkins R; Prioli N Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728 [TBL] [Abstract][Full Text] [Related]
31. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5. Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342 [TBL] [Abstract][Full Text] [Related]
32. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. Weishaar RE; Burrows SD; Kobylarz DC; Quade MM; Evans DB Biochem Pharmacol; 1986 Mar; 35(5):787-800. PubMed ID: 3006691 [TBL] [Abstract][Full Text] [Related]
33. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation. Rybalkin SD; Bornfeldt KE Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733 [No Abstract] [Full Text] [Related]
34. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo. Raeburn D; Karlsson JA J Pharmacol Exp Ther; 1993 Dec; 267(3):1147-52. PubMed ID: 8263775 [TBL] [Abstract][Full Text] [Related]
35. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582. Pagani ED; Dundore RL; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296 [TBL] [Abstract][Full Text] [Related]
37. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788 [TBL] [Abstract][Full Text] [Related]
38. Changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscle of cardiomyopathic hamsters. Masunaga R; Nagasaka A; Sawai Y; Hayakawa N; Nakai A; Hotta K; Kato Y; Hishida H; Takahashi H; Naka M; Shimada Y; Tanaka T; Hidaka H; Itoh M J Mol Cell Cardiol; 2004 Sep; 37(3):767-74. PubMed ID: 15350849 [TBL] [Abstract][Full Text] [Related]
39. Inotropic responses to selective (RO 20-1724 and SQ 65,442) and nonselective (trequinsin) inhibitors of cyclic AMP-specific class IV phosphodiesterase in newborn, immature, and adult rabbit myocardium. Oquist NL; Strada SJ; Artman M Pediatr Res; 1992 Mar; 31(3):300-4. PubMed ID: 1313959 [TBL] [Abstract][Full Text] [Related]